|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/19/24 Procter & Gamble Co. 8-K:7,9 4/19/24 12:3.5M |
Document/Exhibit Description Pages Size 1: 8-K Current Report -- jfmq3fy24earningsslides HTML 73K 2: EX-99.1 CHARTER Jfm Q3 Fy24 Earnings Slides HTML 99K 7: R1 Document and Entity Information HTML 85K 9: XML IDEA XML File -- Filing Summary XML 12K 12: XML XBRL Instance -- jfmq3fy24earningsslides_htm XML 57K 8: EXCEL IDEA Workbook of Financial Report Info XLSX 9K 4: EX-101.DEF XBRL Definitions -- pg-20240419_def XML 66K 5: EX-101.LAB XBRL Labels -- pg-20240419_lab XML 101K 6: EX-101.PRE XBRL Presentations -- pg-20240419_pre XML 72K 3: EX-101.SCH XBRL Schema -- pg-20240419 XSD 24K 10: JSON XBRL Instance as JSON Data -- MetaLinks 19± 26K 11: ZIP XBRL Zipped Folder -- 0000080424-24-000048-xbrl Zip 56K
|
i Ohio
|
i 31-0411980 |
|||
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number) |
(I.R.S. Employer Identification No.)
|
|
i ☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
i ☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
i ☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
i ☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
| i Common Stock without Par Value |
i PG |
i NYSE |
||
| i 0.500% Notes due 2024 |
i PG24A |
i NYSE |
||
| i 0.625% Notes due 2024 |
i PG24B |
i NYSE |
||
| i 1.375% Notes due 2025 |
i PG25 |
i NYSE |
||
| i 0.110% Notes due 2026 |
i PG26D |
i NYSE |
||
| i 3.25% EUR Notes due 2026 |
i PG26E | i NYSE |
||
| i 4.875% EUR notes due May 2027 |
i PG27A |
i NYSE |
||
| i 1.200% Notes due 2028 |
i PG28 |
i NYSE |
||
| i 1.250% Notes due 2029 |
i PG29B |
i NYSE |
||
| i 1.800% Notes due 2029 |
i PG29A |
i NYSE |
||
| i 6.250% GBP notes due January 2030 |
i PG30 |
i NYSE |
||
| i 0.350% Notes due 2030 |
i PG30C |
i NYSE |
||
| i 0.230% Notes due 2031 |
i PG31A |
i NYSE |
||
| i 3.25% EUR Notes due 2031 | i PG31B | i NYSE |
||
| i 5.250% GBP notes due January 2033 |
i PG33 |
i NYSE |
||
| i 1.875% Notes due 2038 |
i PG38 |
i NYSE |
||
| i 0.900% Notes due 2041 |
i PG41 |
i NYSE |
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
|
||
|
|
|
Emerging growth company
|
i ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended tramsition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||
|
ITEM 9.01 FINANCIAL STATEMENTS AND
EXHIBITS
|
|
Exhibit Number
|
|
Description
|
|
99.1
|
|
Informational Slides Provided by The Procter & Gamble Company dated April 19, 2024
|
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Exhibit Number
|
|
Description
|
|
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 4/19/24 | 8-K | ||
| List all Filings | ||||